dc.creator | de Fatima, A | |
dc.creator | Marquissolo, C | |
dc.creator | de Albuquerque, S | |
dc.creator | Carraro-Abrahao, AA | |
dc.creator | Pilli, RA | |
dc.date | 2006 | |
dc.date | OCT | |
dc.date | 2014-11-14T07:03:23Z | |
dc.date | 2015-11-26T16:04:59Z | |
dc.date | 2014-11-14T07:03:23Z | |
dc.date | 2015-11-26T16:04:59Z | |
dc.date.accessioned | 2018-03-28T22:54:06Z | |
dc.date.available | 2018-03-28T22:54:06Z | |
dc.identifier | European Journal Of Medicinal Chemistry. Elsevier France-editions Scientifiques Medicales Elsevier, v. 41, n. 10, n. 1210, n. 1213, 2006. | |
dc.identifier | 0223-5234 | |
dc.identifier | WOS:000241909800011 | |
dc.identifier | 10.1016/j.ejmech.2006.05.010 | |
dc.identifier | http://www.repositorio.unicamp.br/jspui/handle/REPOSIP/77034 | |
dc.identifier | http://www.repositorio.unicamp.br/handle/REPOSIP/77034 | |
dc.identifier | http://repositorio.unicamp.br/jspui/handle/REPOSIP/77034 | |
dc.identifier.uri | http://repositorioslatinoamericanos.uchile.cl/handle/2250/1265623 | |
dc.description | Sixteen 5,6-dihydro-2H-pyran-2-ones were evaluated in in vitro assay against trypomastigotes forms of Trypanosoma cruzi, the causative agent of Chagas' disease. A structure-activity relationship study (SAR) allowed us to establish the relevant structural features for the trypanocidal activity of goniothalamin analogues against T. cruzi. In fact, non-natural form of goniothalamin (ent-1) was threefold more potent than the natural one (1). In addition, we have identified analogues 9 and 10 (both displaying S configuration) as the highest potent compounds against T. cruzi with IC50 = 0.12 and 0.09 mM (IC50 value for crystal violet was 0.08 mM) whereas significantly lower toxicities were observed when these compounds were evaluated under LLC-MK2 lineage cells (1.38 and 4.89 mM, respectively). In addition, epoxides derivatives 12 and ent-12 were shown to be more potent than the corresponding stereoisomers 2 and ent-2 and non-natural argentilactone (ent-3, IC50 = 0.47 mM) was twofold more potent than natural argentilactone (3, IC50 = 0.94 mM). (c) 2006 Elsevier Masson SAS. All rights reserved. | |
dc.description | 41 | |
dc.description | 10 | |
dc.description | 1210 | |
dc.description | 1213 | |
dc.language | en | |
dc.publisher | Elsevier France-editions Scientifiques Medicales Elsevier | |
dc.publisher | Paris | |
dc.publisher | França | |
dc.relation | European Journal Of Medicinal Chemistry | |
dc.relation | Eur. J. Med. Chem. | |
dc.rights | fechado | |
dc.rights | http://www.elsevier.com/about/open-access/open-access-policies/article-posting-policy | |
dc.source | Web of Science | |
dc.subject | 5,6-dihydropyran-2-ones | |
dc.subject | goniothalamin analogues | |
dc.subject | trypanocidal activity | |
dc.subject | Cancer-cell Lines | |
dc.subject | Bryonopsis-laciniosa | |
dc.subject | Cytotoxic Activity | |
dc.subject | Chagas-disease | |
dc.subject | Goniothalamin | |
dc.subject | Derivatives | |
dc.subject | (r)-argentilactone | |
dc.subject | (r)-goniothalamin | |
dc.subject | Argentilactone | |
dc.subject | 5-nitrofuryl | |
dc.title | Trypanocidal activity of 5,6-dihydropyran-2-ones against free trypomastigotes forms of Trypanosoma cruzi | |
dc.type | Artículos de revistas | |